{"id":315512,"date":"2020-01-31T20:00:31","date_gmt":"2020-02-01T04:00:31","guid":{"rendered":"https:\/\/nai500.com\/blog\/2020\/01\/verastem-oncology-announces-dosing-of-first-patient-in-cspcs-chinese-study-evaluating-copiktra\/"},"modified":"2020-01-31T21:50:45","modified_gmt":"2020-02-01T05:50:45","slug":"verastem-%e8%88%87%e7%9f%b3%e8%97%a5%e9%9b%86%e5%9c%98%e5%ae%8c%e6%88%90-copiktra-%e7%9a%84%e4%b8%ad%e5%9c%8b%e9%a6%96%e4%be%8b%e6%82%a3%e8%80%85%e7%b5%a6%e8%97%a5","status":"publish","type":"post","link":"https:\/\/nai500.com\/zh-hant\/blog\/2020\/01\/verastem-%e8%88%87%e7%9f%b3%e8%97%a5%e9%9b%86%e5%9c%98%e5%ae%8c%e6%88%90-copiktra-%e7%9a%84%e4%b8%ad%e5%9c%8b%e9%a6%96%e4%be%8b%e6%82%a3%e8%80%85%e7%b5%a6%e8%97%a5\/","title":{"rendered":"Verastem\u8207\u77f3\u85e5\u96c6\u5718\u5b8c\u6210COPIKTRA\u00ae\u7684\u4e2d\u570b\u9996\u4f8b\u60a3\u8005\u7d66\u85e5"},"content":{"rendered":"<p>Verastem Oncology Inc. (Nasdaq: VSTM)\uff08\u7c21\u7a31\u201cVerastem\u201d\uff09\u662f\u4e00\u5bb6\u751f\u7269\u88fd\u85e5\u516c\u53f8\uff0c\u81f4\u529b\u65bc\u958b\u767c\u548c\u5546\u696d\u5316\u5c0b\u6c42\u6539\u5584\u764c\u75c7\u60a3\u8005\u751f\u5b58\u7387\u548c\u751f\u6d3b\u8cea\u91cf\u7684\u85e5\u7269\u3002Verastem\u5408\u4f5c\u5925\u4f34\u77f3\u85e5\u96c6\u5718\u88fd\u85e5\u96c6\u5718\u6709\u9650\u516c\u53f8\uff08HKEx\uff1a1093\uff09\uff08\u201c\u77f3\u85e5\u96c6\u5718\u201d\uff09\u662f\u4e2d\u570b\u9818\u5148\u7684\u88fd\u85e5\u516c\u53f8\uff0c\u5df2\u5728\u4e00\u9805\u95dc\u9375\u7684\u4e2d\u570b\u6a4b\u63a5\u7814\u7a76\u4e2d\u5c0d\u9996\u4f4d\u60a3\u8005\u9032\u884c\u7d66\u85e5\uff0c\u8a72\u7814\u7a76\u8a55\u4f30\u4e86\u5fa9\u767c\u6216\u96e3\u6cbb\u6027\u6ffe\u6ce1\u6027\u6dcb\u5df4\u7624\u60a3\u8005\u4f7f\u7528COPIKTRA\u00ae\uff08duvelisib\uff09\u7684\u7642\u6548\u3002 COPIKTRA\u662f\u78f7\u9178\u808c\u91873\u6fc0\u9176\uff08PI3K\uff09\u7684\u53e3\u670d\u6291\u5236\u5291\uff0c\u4e5f\u662f\u7f8e\u570b\u7b2c\u4e00\u500b\u6279\u51c6\u7684PI3K-\u03b4\u548cPI3K-\u03b3\u96d9\u91cd\u6291\u5236\u5291\u3002<\/p>\n<p>Verastem\u9996\u5e2d\u57f7\u884c\u5b98Brian Stuglik\u8aaa\uff1a\u201c\u6839\u64da\u77f3\u85e5\u96c6\u5718\u5728\u4e2d\u570b\u6210\u529f\u958b\u767c\u548c\u5546\u696d\u5316\u816b\u7624\u7522\u54c1\u7684\u826f\u597d\u5f80\u7e3e\uff0c\u6211\u5011\u5f88\u9ad8\u8208\u8207\u77f3\u85e5\u96c6\u5718\u9032\u884c\u9019\u9805\u8a66\u9a57\uff0c\u81f4\u529b\u65bc\u70ba\u4e2d\u570b\u7684\u6ffe\u6ce1\u6027\u6dcb\u5df4\u7624\u60a3\u8005\u63d0\u4f9b\u65b0\u7684\u9078\u64c7\u3002\u8a72\u8a66\u9a57\u4e2d\u7684\u9996\u4f4d\u60a3\u8005\u662f\u6211\u5011\u5c07COPIKTRA\u5e36\u7d66\u5168\u7403\u60a3\u8005\u7684\u4f7f\u547d\u4e2d\u7684\u95dc\u9375\u4e00\u6b65\u3002\u201d<\/p>\n<p>2018\u5e749\u6708\uff0cVerastem\u8207\u77f3\u85e5\u96c6\u5718\u7c3d\u7f72\u4e86\u4e00\u9805\u7368\u5bb6\u8a31\u53ef\u5354\u8b70\uff0c\u4ee5\u4f9b\u77f3\u85e5\u96c6\u5718\u958b\u767c\u548c\u5546\u696d\u5316Verastem\u7684COPIKTRA\uff0c\u4ee5\u6cbb\u7642\u4e2d\u570b\u7684\u6240\u6709\u816b\u7624\u9069\u61c9\u75c7\u3002\u77f3\u85e5\u96c6\u5718\u7684\u55ae\u81c2\u3001\u958b\u653e\u6a19\u7c3d\u3001\u591a\u4e2d\u5fc3\u6a1e\u7d10\u7814\u7a76\u65e8\u5728\u8a55\u4f30duvelisib\u5c0d\u88ab\u8a3a\u65b7\u60a3\u6709\u5fa9\u767c\u6027\u6216\u96e3\u6cbb\u6027\u6ffe\u6ce1\u6027\u6dcb\u5df4\u7624\u60a3\u8005\u7684\u6297\u816b\u7624\u6d3b\u6027\u548c\u5b89\u5168\u6027\u3002\u6839\u64daVerastem\u7684DYNAMO 2\u671f\u7814\u7a76\u4e2d\u89c0\u5bdf\u5230\u7684\u7642\u6548\u548c\u5b89\u5168\u6027\uff0c\u8a72\u7814\u7a76\u6709\u671b\u4f5c\u70ba\u904e\u6e21\u7814\u7a76\u3002\u9019\u9805\u7814\u7a76\u7684\u7d50\u679c\u5c07\u6210\u70baCOPIKTRA\u5728\u4e2d\u570b\u6cbb\u7642\u5fa9\u767c\u6027\u6216\u96e3\u6cbb\u6027\u6ffe\u6ce1\u6027\u6dcb\u5df4\u7624\u7684\u6cd5\u898f\u4f9d\u64da\u7684\u57fa\u790e\u3002<\/p>\n<p>COPIKTRA\u65bc2018\u5e749\u6708\u7372\u5f97\u7f8e\u570b\u98df\u54c1\u85e5\u54c1\u76e3\u7763\u7ba1\u7406\u5c40\uff08FDA\uff09\u7684\u6279\u51c6\uff0c\u7528\u65bc\u81f3\u5c11\u7d93\u904e\u5169\u6b21\u4ee5\u4e0a\u6cbb\u7642\u7684\u5fa9\u767c\u6216\u96e3\u6cbb\u6027\u6162\u6027\u6dcb\u5df4\u7d30\u80de\u767d\u8840\u75c5\/\u5c0f\u6dcb\u5df4\u7d30\u80de\u6dcb\u5df4\u7624\uff08CLL \/ SLL\uff09\u7684\u6210\u4eba\u60a3\u8005\u3002 COPIKTRA\u4e5f\u7372\u5f97\u4e86\u52a0\u901f\u6279\u51c6\uff0c\u7528\u65bc\u6cbb\u7642\u60a3\u6709\u5fa9\u767c\u6027\u6216\u96e3\u6cbb\u6027\u6ffe\u6ce1\u6027\u6dcb\u5df4\u7624\u7684\u6210\u5e74\u60a3\u8005\u3002 \u6ffe\u6ce1\u6027\u6dcb\u5df4\u7624\u7684\u7e7c\u7e8c\u6279\u51c6\u53ef\u80fd\u53d6\u6c7a\u65bc\u9a57\u8b49\u6027\u8a66\u9a57\u4e2d\u5c0d\u81e8\u5e8a\u76ca\u8655\u7684\u9a57\u8b49\u548c\u63cf\u8ff0\u3002<\/p>\n<p>COPIKTRA\u662f\u78f7\u9178\u808c\u91873\u6fc0\u9176\uff08PI3K\uff09\u7684\u53e3\u670d\u6291\u5236\u5291\uff0c\u4e5f\u662f\u7f8e\u570b\u9996\u500b\u6279\u51c6\u7684PI3K-delta\u548cPI3K-\u03b3\u96d9\u91cd\u6291\u5236\u5291\uff0cPI3K-delta\u548cPI3K-\u03b3\u662f\u5df2\u77e5\u7684\u5169\u7a2e\u9176\uff0c\u53ef\u5e6b\u52a9\u652f\u6301\u60e1\u6027B\u7d30\u80de\u7684\u751f\u9577\u548c\u5b58\u6d3b\u3002PI3K\u4fe1\u865f\u50b3\u5c0e\u53ef\u80fd\u5c0e\u81f4\u60e1\u6027B\u7d30\u80de\u589e\u6b96\uff0c\u4e26\u88ab\u8a8d\u70ba\u5728\u652f\u6301\u6027\u816b\u7624\u5fae\u74b0\u5883\u7684\u5f62\u6210\u548c\u7dad\u6301\u4e2d\u767c\u63ee\u4f5c\u7528\u3002<\/p>\n<p>\u82f1\u6587\u4f86\u6e90\uff1aBiospace<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Verastem Oncology Inc. (Nasdaq: VSTM), (Verastem Oncology or the Company) today announced that its partner CSPC Pharmaceutical Group Limited (HKEx: 1093) (CSPC)<\/p>\n","protected":false},"author":9,"featured_media":315506,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":"","_links_to":"","_links_to_target":""},"categories":[426],"tags":[563,644,570,564],"class_list":["post-315512","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-market-news-zh-hant","tag--zh-hant","tag-644","tag-570","tag-564","sectors-life-science-zh-hant","locations-china-zh-hant","locations-us-zh-hant","exchange-nasdaq-zh-hant"],"acf":[],"_links":{"self":[{"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/posts\/315512","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/users\/9"}],"replies":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/comments?post=315512"}],"version-history":[{"count":0,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/posts\/315512\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/media\/315506"}],"wp:attachment":[{"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/media?parent=315512"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/categories?post=315512"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/tags?post=315512"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}